Edgar R. Kramer, PD Dr. rer. nat. - Publications

Affiliations: 
Junior Research Group Development and Maintenance of the Nervous System ZMNH Center For Molecular Neurobiology Hamburg 
Area:
neurotophic factors, dopaminergic system, Parkinson, Drug addiction
Website:
http://www.zmnh.uni-hamburg.de/zmnh/groups/kramer/kramer.html

30/45 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Conway JA, Kinsman G, Kramer ER. The Role of NEDD4 E3 Ubiquitin-Protein Ligases in Parkinson's Disease. Genes. 13. PMID 35328067 DOI: 10.3390/genes13030513  0.684
2022 Conway JA, Kramer ER. Is activation of GDNF/RET signaling the answer for successful treatment of Parkinson's disease? A discussion of data from the culture dish to the clinic. Neural Regeneration Research. 17: 1462-1467. PMID 34916419 DOI: 10.4103/1673-5374.327330  0.704
2020 Conway JA, Ince S, Black S, Kramer ER. GDNF/RET signaling in dopamine neurons in vivo. Cell and Tissue Research. PMID 32870383 DOI: 10.1007/S00441-020-03268-9  0.698
2020 Baaske MK, Kramer ER, Meka DP, Engler G, Engel AK, Moll CKE. Parkin deficiency perturbs striatal circuit dynamics. Neurobiology of Disease. 104737. PMID 31923460 DOI: 10.1016/J.Nbd.2020.104737  0.501
2018 Drinkut A, Tillack K, Meka DP, Schulz JB, Kügler S, Kramer ER. Correction to: Ret is essential to mediate GDNF's neuroprotective and neuroregenerative effect in a Parkinson disease mouse model. Cell Death & Disease. 9: 634. PMID 29802278 DOI: 10.1038/S41419-018-0636-4  0.466
2016 Drinkut A, Tillack K, Meka DP, Schulz JB, Kügler S, Kramer ER. Ret is essential to mediate GDNF's neuroprotective and neuroregenerative effect in a Parkinson disease mouse model. Cell Death & Disease. 7: e2359. PMID 27607574 DOI: 10.1038/Cddis.2016.263  0.6
2016 Friedemann T, Ying Y, Wang W, Kramer ER, Schumacher U, Fei J, Schröder S. Neuroprotective Effect of Coptis chinensis in MPP[Formula: see text] and MPTP-Induced Parkinson's Disease Models. The American Journal of Chinese Medicine. 1-19. PMID 27430912 DOI: 10.1142/S0192415X16500506  0.488
2016 Baaske M, Kramer E, Meka D, Engler G, Engel A, Moll C. FV 6. Striatal Microcircuit alterations in a mouse model of preclinical parkinsonism Clinical Neurophysiology. 127: e213. DOI: 10.1016/J.Clinph.2016.05.023  0.539
2015 Kramer ER. The neuroprotective and regenerative potential of parkin and GDNF/Ret signaling in the midbrain dopaminergic system. Neural Regeneration Research. 10: 1752-3. PMID 26807104 DOI: 10.4103/1673-5374.165295  0.572
2015 Kramer ER, Liss B. GDNF-Ret signaling in midbrain dopaminergic neurons and its implication for Parkinson disease. Febs Letters. 589: 3760-72. PMID 26555190 DOI: 10.1016/J.Febslet.2015.11.006  0.589
2015 Tillack K, Aboutalebi H, Kramer ER. An Efficient and Versatile System for Visualization and Genetic Modification of Dopaminergic Neurons in Transgenic Mice. Plos One. 10: e0136203. PMID 26291828 DOI: 10.1371/Journal.Pone.0136203  0.513
2015 Kramer ER. Crosstalk of parkin and Ret in dopaminergic neurons. Oncotarget. 6: 15704-5. PMID 26202959 DOI: 10.18632/Oncotarget.4465  0.582
2015 Meka DP, Müller-Rischart AK, Nidadavolu P, Mohammadi B, Motori E, Ponna SK, Aboutalebi H, Bassal M, Annamneedi A, Finckh B, Miesbauer M, Rotermund N, Lohr C, Tatzelt J, Winklhofer KF, ... Kramer ER, et al. Parkin cooperates with GDNF/RET signaling to prevent dopaminergic neuron degeneration. The Journal of Clinical Investigation. 125: 1873-85. PMID 25822020 DOI: 10.1172/Jci79300  0.575
2015 Kramer ER. The neuroprotective and regenerative potential of parkin and GDNF/ Ret signaling in the midbrain dopaminergic system Neural Regeneration Research. 10: 1752-1753. DOI: 10.4103/1673-5374.165295  0.422
2015 Kramer ER, Liss B. GDNF-Ret signaling in midbrain dopaminergic neurons and its implication for Parkinson disease Febs Letters. 589: 3760-3772. DOI: 10.1016/j.febslet.2015.11.006  0.483
2012 Gonzalez-Reyes LE, Verbitsky M, Blesa J, Jackson-Lewis V, Paredes D, Tillack K, Phani S, Kramer ER, Przedborski S, Kottmann AH. Sonic hedgehog maintains cellular and neurochemical homeostasis in the adult nigrostriatal circuit. Neuron. 75: 306-19. PMID 22841315 DOI: 10.1016/J.Neuron.2012.05.018  0.55
2010 Aron L, Klein P, Pham TT, Kramer ER, Wurst W, Klein R. Pro-survival role for Parkinson's associated gene DJ-1 revealed in trophically impaired dopaminergic neurons. Plos Biology. 8: e1000349. PMID 20386724 DOI: 10.1371/Journal.Pbio.1000349  0.581
2010 Lücking CB, Lichtner P, Kramer ER, Gieger C, Illig T, Dichgans M, Berg D, Gasser T. Polymorphisms in the receptor for GDNF (RET) are not associated with Parkinson's disease in Southern Germany Neurobiology of Aging. 31: 167-168. PMID 18436345 DOI: 10.1016/J.Neurobiolaging.2008.03.006  0.47
2008 Deininger K, Eder M, Kramer ER, Zieglgänsberger W, Dodt HU, Dornmair K, Colicelli J, Klein R. The Rab5 guanylate exchange factor Rin1 regulates endocytosis of the EphA4 receptor in mature excitatory neurons. Proceedings of the National Academy of Sciences of the United States of America. 105: 12539-44. PMID 18723684 DOI: 10.1073/Pnas.0801174105  0.429
2008 Mishra A, Knerr B, Paixão S, Kramer ER, Klein R. The protein dendrite arborization and synapse maturation 1 (Dasm-1) is dispensable for dendrite arborization. Molecular and Cellular Biology. 28: 2782-91. PMID 18268009 DOI: 10.1128/Mcb.02102-07  0.413
2007 Kowsky S, Pöppelmeyer C, Kramer ER, Falkenburger BH, Kruse A, Klein R, Schulz JB. RET signaling does not modulate MPTP toxicity but is required for regeneration of dopaminergic axon terminals. Proceedings of the National Academy of Sciences of the United States of America. 104: 20049-54. PMID 18056810 DOI: 10.1073/Pnas.0706177104  0.583
2007 Kramer ER, Aron L, Ramakers GM, Seitz S, Zhuang X, Beyer K, Smidt MP, Klein R. Absence of Ret signaling in mice causes progressive and late degeneration of the nigrostriatal system. Plos Biology. 5: e39. PMID 17298183 DOI: 10.1371/Journal.Pbio.0050039  0.571
2006 Kramer ER, Knott L, Su F, Dessaud E, Krull CE, Helmbacher F, Klein R. Cooperation between GDNF/Ret and ephrinA/EphA4 signals for motor-axon pathway selection in the limb. Neuron. 50: 35-47. PMID 16600854 DOI: 10.1016/J.Neuron.2006.02.020  0.408
2001 SØrensen CS, Lukas C, Kramer ER, Peters JM, Bartek J, Lukas J. A conserved cyclin-binding domain determines functional interplay between anaphase-promoting complex-Cdh1 and cyclin A-Cdk2 during cell cycle progression Molecular and Cellular Biology. 21: 3692-3703. PMID 11340163 DOI: 10.1128/Mcb.21.11.3692-3703.2001  0.426
2000 Sorensen CS, Lukas C, Kramer ER, Peters JM, Bartek J, Lukas J. Nonperiodic activity of the human anaphase-promoting complex-Cdh1 ubiquitin ligase results in continuous DNA synthesis uncoupled from mitosis Molecular and Cellular Biology. 20: 7613-7623. PMID 11003657 DOI: 10.1128/Mcb.20.20.7613-7623.2000  0.415
2000 Petersen BO, Wagener C, Marinoni F, Kramer ER, Melixetian M, Lazzerini Denchi E, Gieffers C, Matteucci C, Peters JM, Helin K. Cell cycle- and cell growth-regulated proteolysis of mammalian CDC6 is dependent on APC-CDH1. Genes & Development. 14: 2330-43. PMID 10995389 DOI: 10.1101/Gad.832500  0.419
2000 Kramer ER, Scheuringer N, Podtelejnikov AV, Mann M, Peters JM. Mitotic regulation of the APC activator proteins CDC20 and CDH1 Molecular Biology of the Cell. 11: 1555-1569. PMID 10793135 DOI: 10.1091/Mbc.11.5.1555  0.408
1999 Lukas C, Sørensen CS, Kramer E, Santoni-Rugiu E, Lindeneg C, Peters JM, Bartek J, Lukas J. Accumulation of cyclin B1 requires E2F and cyclin-A-dependent rearrangement of the anaphase-promoting complex. Nature. 401: 815-8. PMID 10548110 DOI: 10.1038/44611  0.432
1999 Gieffers C, Peters BH, Kramer ER, Dotti CG, Peters JM. Expression of the CDH1-associated form of the anaphase-promoting complex in postmitotic neurons. Proceedings of the National Academy of Sciences of the United States of America. 96: 11317-22. PMID 10500174 DOI: 10.1073/Pnas.96.20.11317  0.467
1998 Kramer ER, Gieffers C, Hölzl G, Hengstschläger M, Peters JM. Activation of the human anaphase-promoting complex by proteins of the CDC20/Fizzy family. Current Biology : Cb. 8: 1207-10. PMID 9811605 DOI: 10.1016/S0960-9822(07)00510-6  0.418
Low-probability matches (unlikely to be authored by this person)
2001 Geley S, Kramer E, Gieffers C, Gannon J, Peters JM, Hunt T. Anaphase-promoting complex/cyclosome-dependent proteolysis of human cyclin A starts at the beginning of mitosis and is not subject to the spindle assembly checkpoint. The Journal of Cell Biology. 153: 137-48. PMID 11285280 DOI: 10.1083/Jcb.153.1.137  0.3
2001 Reimann JD, Freed E, Hsu JY, Kramer ER, Peters JM, Jackson PK. Emi1 is a mitotic regulator that interacts with Cdc20 and inhibits the anaphase promoting complex. Cell. 105: 645-55. PMID 11389834 DOI: 10.1016/S0092-8674(01)00361-0  0.296
2006 Linn SA, Su F, Knott L, Kramer E, Klein R, Krull CE. Ret and EphA4 signaling in motor axon pathfinding Developmental Biology. 295: 364-365. DOI: 10.1016/J.Ydbio.2006.04.121  0.27
2015 Kramer ER. Crosstalk of parkin and Ret in dopaminergic neurons Oncotarget. 6: 15704-15705.  0.258
2008 Becker K, Jährling N, Kramer ER, Schnorrer F, Dodt HU. Ultramicroscopy: 3D reconstruction of large microscopical specimens. Journal of Biophotonics. 1: 36-42. PMID 19343633 DOI: 10.1002/Jbio.200710011  0.246
2022 Chohan MO, Kopelman JM, Yueh H, Fazlali Z, Greene N, Harris AZ, Balsam PD, Leonardo ED, Kramer ER, Veenstra-VanderWeele J, Ahmari SE. Developmental impact of glutamate transporter overexpression on dopaminergic neuron activity and stereotypic behavior. Molecular Psychiatry. PMID 35058566 DOI: 10.1038/s41380-021-01424-3  0.239
2012 Ertürk A, Mauch CP, Hellal F, Förstner F, Keck T, Becker K, Jährling N, Steffens H, Richter M, Hübener M, Kramer E, Kirchhoff F, Dodt HU, Bradke F. Three-dimensional imaging of the unsectioned adult spinal cord to assess axon regeneration and glial responses after injury. Nature Medicine. 18: 166-71. PMID 22198277 DOI: 10.1038/Nm.2600  0.226
2008 Jährling N, Becker K, Kramer ER, Dodt HU. 3D-Visualization of nerve fiber bundles by ultramicroscopy Medical Laser Application. 23: 209-215. DOI: 10.1016/J.Mla.2008.06.001  0.203
2010 Saghafi S, Becker K, Jährling N, Richter M, Kramer ER, Dodt HU. Image enhancement in ultramicroscopy by improved laser light sheets. Journal of Biophotonics. 3: 686-95. PMID 20575105 DOI: 10.1002/Jbio.201000047  0.198
2015 Tillack K, Aboutalebi H, Kramer ER. An efficient and versatile system for visualization and genetic modification of dopaminergic neurons in transgenic mice Plos One. 10. DOI: 10.1371/journal.pone.0136203  0.194
2019 Jährling N, Couillard-Deprés S, Becker K, Saghafi S, Wegenast-Braun B, Kramer ER, Weiler R, Dodt HU. P36 Lightsheet microscopy: Ultramicroscopy in fundamental neuroscience research Clinical Neurophysiology. 130. DOI: 10.1016/J.Clinph.2019.04.689  0.181
2013 Kramer ER, Morey AM, Staruch M, Suib SL, Jain M, Budnick JI, Wei M. Synthesis and characterization of iron-substituted hydroxyapatite via a simple ion-exchange procedure Journal of Materials Science. 48: 665-673. DOI: 10.1007/S10853-012-6779-2  0.035
2013 Charles LF, Kramer ER, Shaw MT, Olson JR, Wei M. Self-reinforced composites of hydroxyapatite-coated PLLA fibers: fabrication and mechanical characterization. Journal of the Mechanical Behavior of Biomedical Materials. 17: 269-77. PMID 23127637 DOI: 10.1016/J.Jmbbm.2012.09.007  0.033
1990 Eremenko AI, Chavdar NI, Kungurova SM, Faustova AM, Moiseeva LI, Eremenko IG, Kramer ER. On treatment of vascular optic neuropathies Oftalmologicheskii Zhurnal. 45: 25-28.  0.019
2013 Piccinini PE, Kramer ER. Unsupervised machine learning for the accurate classification of the discourse marker like in code-switching utterances Proceedings of Meetings On Acoustics. 19. DOI: 10.1121/1.4799757  0.017
Hide low-probability matches.